Mayo Clinic, Barcelona, Haifa, Osaka and Rio de Janeiro, CHEPS (contact heat evoked potentials) developed as a practical clinical diagnostic test (substitute for the invasive skin biopsies for diagnosing small fibre neuropathy), led international normative data group.Data presentation at American Neurological Association, ANA, 2013, 2011 - 2013
European Federation of Neurological Societies Task Force, UK representative of the European Federation of Neurological Societies Task Force on Pain Management, responsibility to address required standards of quantitative sensory testing and skin / nerve biopsies in the assessment of patients with neuropathic pain - 2008
New UK Govt. Department of Business, Innovation and Skills, UK drug development initiative, with Royal Society of Chemistry, linking key academics with pharma in UK and Japan, UK delegate and speaker at the British Embassy in Tokyo workshop on novel Drug Target Validation in January 2013
GlaxoSmithKline, Successful Phase II clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury. 2011. Drug first in class.
Spinifex Pharma,, EMA401 clinical trial positive results for EMA401 in postherpetic neuralgia: results presented at the World Congress of Pain in Milan in 2012. First in class
Creabilis Pharma,, successful clinical trial for itch with CT327. 2013. First in class.
Astellas,, clinical study with Qutenza, high dose capsaicin patch, new indication to prevent pain from subcutaneous infusion of prostacyclin in patients with pulmonary hypertension. 2013
Speaker, European Pain Congress (EFIC), Florence, Italy, 2013
Speaker at Drug validation, British Embassy Tokyo / Royal Society of Chemistry, Tokyo, Japan, 2013
Speaker, International Society of Hypertension, Sydney / Hunter Valley, Australia, 2012
Invited speaker, World Congress of Neurology, Marrakesh, Morocco, 2011
Speaker at the Combined Orthopaedic Associations meeting, Combined Orthopaedic Associations (USA, Canada, UK),, Glasgow, UK, 2010
Speaker at the meeting on Neurotoxins, The Royal Society,, UK, 2010
Invited Speaker, Association of British Neurologists Annual meeting, ., Bournemouth, UK, 2010
Invited Speaker, International Congress of Clinical Neurophysiology, Kobe, Japan, 2010